Peak ProcessingASX:PKP -5.56% PS Ratio is 1.13 as of Jul. 06, 2026, which is 14% above its 10-year median of 0.99. The stock has 7 warning signs investors should review. Among 952 Drug Manufacturers companies, Peak Processing ranks better than 71.85% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Peak Processing's share price is A$0.017.
Peak Processing's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.02. Hence, Peak Processing's PS Ratio for today is 1.13.
The historical rank and industry rank for Peak Processing's PS Ratio or its related term are showing as below:
ASX:PKP'
s PS Ratio Range Over the Past 10 Years
Min: 0.23 Med: 0.99 Max: 239
Current: 1.13
During the past 7 years, Peak Processing's highest PS Ratio was 239.00. The lowest was 0.23. And the median was 0.99.
ASX:PKP's PS Ratio is ranked better than 71.85% of 952
companies
in the Drug Manufacturers industry
Industry Median: 2.315
vs ASX:PKP: 1.13
Peak Processing Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Peak Processing was -73.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -24.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 8.70% per year.
During the past 7 years, Peak Processing's highest 3-Year average Revenue per Share Growth Rate was 136.30% per year. The lowest was -24.90% per year. And the median was 33.95% per year.
Back to Basics: PS Ratio
Peak Processing (ASX:PKP) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Peak Processing PS Ratio Related Terms
Peak Processing PS Ratio Historical Data
* Premium members only.
The historical data trend for Peak Processing's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Peak Processing's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peak Processing PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Peak Processing's PS Ratio distribution charts can be found below:
* The bar in red indicates where Peak Processing's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Peak Processing's Share Price of today is A$0.017.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Peak Processing's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Peak Processing (ASX:PKP) has a PS Ratio of 1.13 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Peak Processing and its competitors. This is 14% above median its historical median of 0.99. Over the past decade, Peak Processing's PS Ratio has ranged from 0.23 to 239.00. According to the industry distribution chart, Peak Processing ranks #268 out of 952 companies in the Drug Manufacturers industry, placing it in the top 28.2%.
Is Peak Processing's PS Ratio too high?
Peak Processing's current PS Ratio of 1.13 is 14% above median its 10-year median of 0.99. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 239.00. The Drug Manufacturers industry median PS Ratio is 2.32. Peak Processing's value of 1.13 is 51.2% below this industry median. Based on the distribution chart, Peak Processing ranks #268 out of 952 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Peak Processing's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peak Processing ranks #268 out of 952 companies for PS Ratio. This puts Peak Processing in the upper half of its industry. The industry median PS Ratio is 2.32. Peak Processing's value of 1.13 is 51.2% below this benchmark. Historically, Peak Processing's own PS Ratio has ranged from 0.23 to 239.00 over the past decade. While the company's 10-year median is 0.99 vs. the industry median of 2.32, Peak Processing has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.32, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peak Processing's current PS Ratio of 1.13 is 51.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Peak Processing and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peak Processing's current PS Ratio is 1.13, which is 14% above median its own 10-year median of 0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peak Processing stock overvalued right now?
Based on GuruFocus' analysis, Peak Processing (ASX:PKP) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 70% above its estimated fair value. The current PS Ratio is 1.13, which is 14% above median its 10-year median of 0.99 and 51.2% below the Drug Manufacturers industry median of 2.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Peak Processing (ASX:PKP), the current PS Ratio is 1.13 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Peak Processing Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. The products of the company includes cannabis-infused beverage, Hydrocarbon Extracts, oils, vapes, topicals, powder, infused flowers, and others. The company is also engaged in manufacturing services for cannabis products and blending and mixing, bulk filling, packaging, labelling and lab testing work.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PKP has been successfully added to your 